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The kinetics of presentation of influenza virus–derived antigens (Ags), resulting in CD4 T cell 
effector and memory generation, remains undefined. Naive influenza-specific CD4 T cells were 
transferred into mice at various times after influenza infection to determine the duration and 
impact of virus-derived Ag presentation. Ag-specific T cell responses were generated even 
when the donor T cells were transferred 3–4 wk after viral clearance. Transfer of naive CD4 
T cells during early phases of infection resulted in a robust expansion of highly differentiated 
effectors, which then contracted to a small number of memory T cells. Importantly, T cell 
transfer during later phases of infection resulted in a modest expansion of effectors with 
intermediate phenotypes, which were capable of persisting as memory with high efficiency. 
Thus, distinct stages of pathogen-derived Ag presentation may provide a mechanism by which 
T cell heterogeneity is generated and diverse memory subsets are maintained.
 
Efficient presentation of pathogen-derived anti-
gen (Ag), resulting in T cell priming, is essential
for effective immunity to pathogens. Several re-
cent studies have suggested that presentation of
pathogen-derived Ag by DCs is short lived and
is rapidly down-regulated before Ag or patho-
gen clearance (1–3). Alternatively, other studies
have favored the concept that Ag presentation
continues for as long as the pathogen survives
and perhaps even long after viable microor-
ganisms have been eliminated (4, 5). During
immune responses to influenza viruses, CD4
effectors can be heterogeneous with regards to
their activation phenotype, ability to immedi-
ately secrete cytokines, and their migration to
the lung where the virus replicates (6, 7). The
prevailing concept is that there are progressive
stages of T cell differentiation and that only the
most differentiated effectors can migrate to ter-
tiary sites of infection (6) and provide optimum
protection against infection (8–10). However,
these studies did not follow primary CD4 T cell
responses through memory persistence, so it is
not clear from these previous studies what im-
pact  different stages of pathogen-derived Ag
presentation may have on primary effector dif-
ferentiation and what impact this may have on
the formation of a persistent memory population.
To define the role of different stages of
pathogen-derived Ag presentation on the de-
velopment of CD4 effector and memory popu-
lations, we analyzed CD4 T cell responses
when naive CD4 T cells were introduced at
different times after an acute, sublethal influ-
enza virus infection. Influenza infection induces
robust T cell responses, and although live virus
is cleared within the first 10 d of infection (6,
11, 12), we have determined that influenza-
derived Ag presentation to CD4 T cells persists
for 
 
 
 
3 wk after virus clearance. Our results
also show that highly efficient Ag presentation,
resulting in the generation of large numbers of
highly differentiated IFN-
 
 
 
–producing CD4
effectors that migrate to both lymphoid sites
and the lung, is restricted to naive CD4 T cells
that are recruited into the response within the
first week of infection. However, influenza-
derived Ag presentation persists for several
weeks after viral clearance and is capable of
generating modest numbers of highly divided
but progressively less differentiated effectors.
Importantly, the recruitment of naive CD4 T
cells into the response after viral clearance appears
to be necessary in order to generate the greatest
numbers of persisting memory T cells.
 
RESULTS
Persistence of influenza-derived Ag presentation
 
After influenza virus infection in mice, viral
replication was extremely rapid and resulted in
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10
 
6
 
 PFU in the lungs and 10
 
4
 
 PFU in the draining LNs
(DLNs) in the period of 2–5 d after infection (Fig. 1 A). Vi-
ral titers fell thereafter, and live virus was completely cleared
by days 12–14 of infection (Fig. 1 A). Other methods of de-
termining viral presence, including a sensitive PCR-based
test, also found no viral RNA in the lungs after day 12 of in-
fection (unpublished data).
To evaluate whether influenza-derived Ag could be
presented to CD4 T cells after virus clearance, we estab-
lished an adoptive transfer model in which naive CD4 T
cells were transferred into mice at various times after infec-
tion. Fig. 1 B illustrates the model system in which primary
CD4 T cells are transferred (i) during a period of active vi-
rus replication, (ii) during a period when virus is being
cleared, or (iii) after live virus is cleared. Our adoptive
transfer model system used naive CD4 T cells from HNT
TCR transgenic (Tg) mice, which respond to HNT pep-
tide, derived from the PR8 strain of influenza A virus, pre-
sented by MHC class II (13, 14). Carboxyfluorescein diace-
tate succinimidyl ester (CFSE)–labeled naive HNT TCR
Tg donor T cells were transferred into intact mice at various
times after a sublethal infection with live PR8 virus and
were analyzed 7 d after T cell transfer at the peak of the ef-
fector response (6).
The CFSE profiles of donor T cells indicated that sub-
stantial proliferation occurred even when donor T cells were
transferred as late as 21 d after infection, and a small fraction
of donor T cells had divided even when transferred as late as
35 d after infection (Fig. 2 A). The peak of influenza-derived
Ag presentation, resulting in the greatest amount of cell divi-
sion, was limited to the first 14 d after infection because the
fraction of donor T cells that failed to divide within the first
7 d after transfer increased with time when transferred after
live virus clearance (Fig. 2 A). Maximum recovery of re-
sponding donor T cells was seen in all organs when naive
HNT TCR Tg CD4 T cells were transferred when live vi-
rus was still detectable (day 0 or 7 after infection; Fig. 2 B).
Most notably, considerable donor T cell accumulation was
only observed in the lung when naive T cells were trans-
ferred on the same day of infection.
 
Ag specificity of naive CD4 T cell responses
 
We used two separate model systems to establish that donor
CD4 T cell responses were in fact Ag specific and not a
consequence of ongoing inflammatory responses. CD4 T
cells from HNT TCR Tg mice respond specifically to
MHC class II (I-A
 
d
 
) presentation of the HNT peptide en-
coded in residues 126–138 (HNTNGVTAACSHE) of the
PR8 influenza A virus hemagglutinin (HA) protein (13,
Figure 1. Rapid expansion and clearance of virus within 2 wk of 
influenza infection. (A) BALB/c mice were infected with PR8 influenza virus, 
and lungs and DLNs were assayed for live virus by plaque assay at the 
indicated times after infection. Values represent the mean   SD of three 
mice. (B) Experimental setup to examine the responses of naive CD4 T cells 
to (i) active viral infection, (ii) resolving viral infection, or (iii) influenza-
derived Ag presentation after virus clearance can be assayed by transferring 
CFSE-labeled naive CD4 T cells at various times after influenza infection.
Figure 2. Influenza-derived Ag presentation stimulates naive CD4 
T cells for  5 wk after infection. (A) 2   106 CFSE-labeled naive Thy1.1 
HNT TCR Tg CD4 T cells were transferred i.v. into BALB/c mice previously 
infected with PR8 virus. 7 d after T cell transfer, DLNs, spleens, and lungs 
were harvested, and donor T cells were analyzed for CFSE dilution. Histo-
grams were gated on donor Thy1.1 CD4 T cells and are representative of 
three individual mice in all experiments performed in this study. (B) Donor 
T cell numbers were calculated by multiplying the total number of live 
lymphocytes by the frequency of Thy1.1 CD4 T cells. Values represent the 
mean   SD of three mice. Data are representative of three independent 
experiments. 
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14). The X31 strain of influenza A virus does not contain
this specific peptide sequence in its HA protein (15, 16), but
it does induce a robust inflammatory response as indicated
by lymphadenopathy and increased numbers of activated
host T cells (unpublished data) (17). Naive HNT TCR Tg
CD4 T cells were transferred into intact mice at various
times after infection with a sublethal dose of either PR8 or
X31 influenza A virus, and donor T cells were analyzed for
cell division 7 d after transfer. The donor HNT TCR Tg
CD4 T cells remained undivided and comparable with
those transferred into uninfected mice despite the inflam-
mation caused by the X31 virus infection (Fig. 3 A, open
bold histograms). Only PR8 virus infection induced divi-
sion of the transferred HNT TCR Tg CD4 T cells (Fig. 3
A, shaded histograms). This indicated that although the X31
strain of influenza virus induced a strong inflammatory re-
sponse, presentation of PR8-specific HNT peptide was
necessary to drive donor HNT-specific T cell division.
To further establish that division of donor T cells was Ag
specific, we used a second model system in which ovalbu-
min-specific Tg CD4 T cells, purified from DO11.10 Tg
mice (18), were transferred into intact BALB/c mice in-
fected with a sublethal dose of PR8 influenza virus. In these
experiments, the ovalbumin-specific donor T cells did not
divide or accumulate in response to PR8 influenza infection
(unpublished data). These two experimental systems indi-
cated that the proliferation of influenza-specific T cells was
Ag dependent and specific.
Because we observed that a fraction of the donor T cells
(i.e., CFSE
 
hi
 
) had not yet begun to proliferate in response to
influenza-derived Ag presentation within the first 7 d after T
cell transfer, we also examined donor CFSE profiles at later
times after T cell transfer to determine if all of the transferred
donor T cells would eventually divide. Fig. 3 B shows that
Figure 3. Proliferation of naive CD4 T cells to influenza-derived Ag 
presentation is Ag specific. CFSE-labeled naive Thy1.1 HNT TCR Tg CD4 
T cells were transferred i.v. into BALB/c mice previously infected with the 
PR8 strain or the X31 strain of influenza virus, or into noninfected mice. 
(A) Donor T cells were analyzed 7 d after transfer for CFSE dilution. (B) Donor 
T cell responses to PR8 influenza virus infection were assayed 7 and 9 d 
after transfer. Data are representative of two independent experiments.
Figure 4. Long-term presentation of influenza-derived Ag stimulates 
polyclonal CD4 T cell responses. 10   106 CFSE-labeled naive, polyclonal 
Thy1.2 BALB/c CD4 T cells were transferred i.v. into Thy1.1xBALB/c mice 
previously infected with PR8 virus. 7 d after T cell transfer, DLNs, spleens, 
and lungs of three separate mice were pooled, and donor T cells were identi-
fied by gating on Thy1.2 T cells in the CD4 population (A). Numbers represent 
the percentage of donor T cells that had proliferated. (B) The percentage of 
proliferating polyclonal donor CD4 T cells expressing the indicated TCR V  
or V  gene product were determined by staining with 18 different anti-V  
or anti-V  antibodies and gating on the donor T cells that had divided (only 
the positive responders were graphed). 
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although a fraction of donor T cells recovered 7 d after T
cell transfer were undivided (open histograms), by 9 d after
T cell transfer (shaded histograms) 
 
 
 
98% of the recovered
donor T cells had divided.
 
Polyclonal CD4 T cells respond at late phases after infection
 
Natural processing and presentation of pathogen-derived Ag
has been thought to be important for the generation of a
broad repertoire of pathogen-specific T cells. To determine
if multiple influenza-derived Ag epitopes were being pre-
sented after virus clearance, we transferred naive BALB/c
polyclonal (non-Tg) CD4 T cells into intact Thy1.1xBALB/c
mice at various times after infection with PR8 influenza
virus. Polyclonal donor (Thy1.2
 
 
 
) CD4 T cells that had di-
vided, as indicated by the loss of CFSE, were analyzed 7 d
after T cell transfer. Fig. 4 A shows that 
 
 
 
30% of the recov-
ered polyclonal donor T cells had divided, even when trans-
fer of naive T cells was delayed until after virus clearance.
Interestingly, delaying the polyclonal CD4 T cell transfer
until day 7 after infection, which corresponded to the peak
of the endogenous host T cell response, resulted in a sup-
pression of the donor CD4 T cell response. To determine
the diversity of the polyclonal response, we pooled lungs,
DLNs, and spleens and analyzed the TCR V
 
 
 
 and V
 
 
 
 gene
expression on donor T cells that had undergone at least one
round of proliferation. We found that polyclonal donor T
cells expressing 9 different TCRs out of 18 V
 
 
 
 and V
 
 
 
chains screened had divided in response to influenza-derived
Ag epitopes presented for 
 
 
 
21 d after infection (Fig. 4 B).
Strikingly, the diverse polyclonal donor T cell repertoire
changed little as the delay between infection and T cell
transfer increased, suggesting that the Ag-specific response
remained broad even after live virus was cleared.
 
Late phases of influenza-derived Ag presentation can 
generate memory T cells
 
The persisting memory CD4 and CD8 T cell pool is charac-
terized by a substantial degree of heterogeneity in phenotype
and function, but the underlying mechanisms driving this
heterogeneity remain unclear (17, 19–21). Recent results
suggested that heterogeneity of different Ag-specific CD4 T
cell responses are regulated by Ag exposure and load (22,
23). However, these studies only used telomere length and
Ag-specific stimulation for 16 h as an indication of prior Ag
exposure. We were able to more precisely define the time at
which the naive CD4 T cells first encountered pathogen-
derived Ag, and we have determined the impact exposure of
naive CD4 T cells to vastly different levels and durations of
influenza-derived Ag presentation on CD4 T cell persistence
to memory.
To evaluate which conditions of influenza-derived Ag
presentation favor the generation of memory T cells, naive
HNT TCR Tg CD4 T cells (Fig. 5 A) or naive polyclonal
CD4 T cells (Fig. 5 B) were transferred into mice at various
times after influenza infection. Donor T cells were then har-
vested 21 (HNT TCR Tg) or 26 (polyclonal) d after trans-
fer, corresponding with early memory stages of T cell differ-
entiation. At day 21 after T cell transfer, only a small fraction
of the HNT TCR Tg donor effectors persisted as memory,
regardless of their time of transfer after infection (Fig. 5 A).
Analysis of the polyclonal CD4 T cells that had divided in
response to influenza-derived Ag presentation also indicated
that primary T cell responses generated after live virus clear-
ance were capable of persisting as memory (Fig. 5 B).
A clearer picture of the impact of early versus late influ-
enza-derived Ag presentation can be seen in Fig. 5 C, in
which the total number of donor T cells recovered from all
organs is shown at the effector (day 7 after transfer) and the
memory (days 21–26 after transfer) stages of the response.
Naive CD4 T cells, either HNT TCR Tg or polyclonal,
transferred on the same day as infection had the greatest ex-
pansion as effectors but underwent the most contraction to
memory (Fig. 5 C, day 0 transfer). Alternatively, the donor
T cells transferred after live virus had been cleared exhibited
a moderate effector expansion but underwent a much
smaller amount of contraction to memory (Fig. 5 C, day 14
and day 21 transfers). Interestingly, an average of 
 
 
 
2 
 
 
 
 10
 
3
 
of the total memory cells recovered from either the HNT
Figure 5. Late phase influenza-derived Ag presentation generates 
persistent CD4 T cells. CFSE-labeled naive Thy1.1 (A) HNT TCR Tg or (B) 
polyclonal CD4 T cells were transferred i.v. into BALB/c mice previously 
infected with PR8 virus. Total donor T cell numbers from pooled DLNs, 
spleens, and lungs were calculated at (A) 21 or (B) 26 d after T cell transfer. 
Values represent the mean   SD of (A) 12 mice from four independent 
experiments or (B) 3 mice. (C) Total numbers of donor HNT TCR Tg or poly-
clonal CD4 T cells recovered at the effector and memory phases of the 
response were plotted. Data are representative of between two and four 
independent experiments. 
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TCR Tg or polyclonal CD4 T cell populations were found
in the lungs; rather, the majority of the memory T cells were
recovered from the DLNs and spleens (unpublished data).
 
Early phases of influenza-derived Ag presentation result in 
high levels of differentiation
 
We previously reported that a high proportion of donor
CD4 T cells that accumulated in the lungs of infected mice
were CFSE
 
lo
 
 and CD62L
 
lo
 
 and that extensive division cou-
pled with CD62L down-regulation correlated with the most
highly activated IFN-
 
 
 
–producing effectors at the peak of
the CD4 T cell response to influenza infection (6). To deter-
mine whether different phases of influenza-derived Ag pre-
sentation promoted distinct patterns of differentiation, we
analyzed CD62L expression and IFN-
 
 
 
 production by re-
sponding (CFSE
 
lo
 
) donor HNT TCR Tg CD4 effector and
memory T cells. The most highly differentiated 7-d donor
effectors (92% CFSE
 
lo
 
/CD62L
 
lo 
 
and 56% IFN-
 
 
 
 
 
) were
those recovered from the lungs of mice infected on the same
day as T cell transfer (Fig. 6 A). Donor T cells transferred at
times after the first week of infection were progressively
more heterogeneous in their differentiation (Fig. 6 A) and
migrated in extremely low numbers to the lungs at the effec-
tor stage (Fig. 2 B).
Because the transferred donor T cells continued to divide
between days 7 and 9 after transfer (Fig. 3 B), we examined
whether this division resulted in further differentiation by
the memory stage. Analysis of donor HNT TCR Tg CD4
memory T cells, harvested 21 d after transfer, suggested that
the memory T cells remained remarkably unchanged (Fig. 6
B) compared with their level of differentiation as effectors
(Fig. 6 A). Polyclonal donor memory T cells harvested from
the lungs 26 d after T cell transfer also exhibited a similar
heterogeneous pattern of differentiation as the HNT TCR
Tg memory T cells (Fig. 6 C and not depicted). However,
in contrast to the results seen with HNT TCR Tg memory
T cells, highly differentiated IFN-
 
 
 
–producing memory cells
were also recovered from the DLNs and spleens regardless of
the time of naive polyclonal T cell transfer (Fig. 6 C).
 
Late phases of influenza-derived Ag presentation 
contribute to memory
 
Naive CD4 T cells that were transferred after live virus clear-
ance could become persisting memory (Figs. 5 A and 5B).
Thus, we wanted to determine whether recruitment of naive
CD4 T cells could contribute to memory. To determine if
newly generated naive T cells that might enter the periphery
after live virus clearance could contribute to the establish-
ment or maintenance of memory CD4 T cells, we infected
sham and thymectomized mice and tracked endogenous
IFN-
 
 
 
–producing CD4 T cell responses. Thymectomy did
not reduce the number of IFN-
 
 
 
–producing CD4 effector T
cells assessed at day 7 after infection (Fig. 7 A), and there was
a 
 
 
 
50% reduction in the number of IFN-
 
 
 
–producing CD4
memory T cells 26 d into the endogenous influenza-specific
response of thymectomized mice (Fig. 7 B). These results in-
dicate that newly generated naive CD4 T cells, responding to
influenza-derived Ag presentation at times after virus clear-
ance, were contributing to the memory pool.
 
DISCUSSION
 
It has been widely accepted that Ag localization, dose, and
time of Ag/APC availability are each critical mediators in
the regulation of immune responses (2, 3, 8, 10, 24–29).
Figure 6. Highly efficient presentation of influenza Ag is limited to 
the early phase of infection. Naive Thy1.1 CD4 T cells were CFSE labeled 
and transferred i.v. into BALB/c mice previously infected with PR8 virus. 
(A) 7 and (B) 21 d after T cell transfer, responding (CFSElo) donor HNT TCR 
Tg CD4 T cells were assayed for CD62L expression and IFN-  production. 
(C) IFN-  production by responding (CFSElo) polyclonal donor CD4 T cells 
was assayed 26 d after T cell transfer. Data are representative of between 
two and four independent experiments. 
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However, how the efficiency of pathogen-derived Ag pre-
sentation in vivo shifts during an acute infection and
whether distinct stages of pathogen-derived Ag presentation
have different effects on primary CD4 effector and memory
generation had not previously been directly demonstrated.
This study revealed that distinct stages of influenza-derived
Ag presentation dramatically affected the progression of na-
ive CD4 T cells through a primary immune response and
onto memory. Influenza-derived Ag was presented to naive
CD4 T cells long after live virus clearance, and distinct
phases of influenza-derived Ag presentation could dramati-
cally affect the expansion, localization, differentiation, and
persistence of Ag-specific CD4 T cells. Transfer of naive
CD4 T cells during the early phase of influenza infection,
which was characterized by high viral titers and inflamma-
tion, generated a robust primary CD4 effector response with
high numbers of highly differentiated effectors migrating to
the lungs within 7 d of T cell transfer. However, this robust
response appeared to have driven a majority of the effectors
to become terminally differentiated, as they contracted dra-
matically to low numbers of memory CD4 T cells. In con-
trast, the transfer of naive CD4 T cells at times during or af-
ter viral clearance generated more modest effector responses
but underwent less dramatic contraction and resulted in a
greater fraction of donor CD4 T cells capable of surviving to
become memory CD4 T cells.
In accordance with previous observations, few memory
CD4 T cells were ever recovered from the lungs, even though
memory T cells were readily found in the periphery (21). This
was not surprising considering that previous experiments by
Swain et al. demonstrated that only the most highly activated
and differentiated CD4 effectors have the appropriate combi-
nation of tissue homing adhesion molecules to traffic to ter-
tiary sites, such as the lungs; but, as these cells progress to a
resting memory state, they lose this pattern of tissue homing
molecules, and their migration becomes more limited to lym-
phoid sites (30). Additionally, rapidly diminishing inflamma-
tion and Ag availability could also be mitigating factors in the
exclusion of influenza-specific CD4 memory T cells from the
lungs after viral clearance and resolution of infection.
Interestingly, analysis of polyclonal CD4 T cell responses
to different stages of influenza-derived Ag presentation re-
sulted in yet another level of dynamic regulation of the in-
duction of Ag-specific CD4 effector responses, which was
not apparent when analyzing HNT TCR Tg CD4 re-
sponses. Polyclonal CD4 T cells transferred into mice at the
peak of the endogenous T cell response (day 7 after infec-
tion) exhibited a marked reduction in the percentage (Fig. 4
A) and absolute number (Fig. 5 C) of responding (CFSE
 
lo
 
)
effectors as compared with transfers at other times after in-
fection. We believe that this may be a result of competition
between very low numbers of naive influenza-specific CD4
precursors and a large number of highly activated endoge-
nous influenza-specific CD4 effectors. Other investigators
have observed that the burst size of a given virus-specific
CD4 (31–34) or CD8 (35–39) T cell population is sugges-
tive of competition between responding T cells of identical
and different Ag specificity. In fact, the clonal burst size of
CD4 T cells could be hypothesized to be extremely re-
stricted, perhaps because of inefficient Ag presentation of
MHC class II–restricted epitopes. Clonal competition for
peptide–MHC class II is most likely to occur at the peak of
the endogenous CD4 T cell response, which would prevent
a small number of naive influenza-specific polyclonal CD4 T
cells from gaining access to Ag/APCs. This would not be as
evident when transferring large numbers of naive monoclo-
nal TCR Tg CD4 T cells, as they would be better able to
compete for access to Ag/APCs.
Previous experiments by Wong and Pamer presented ev-
idence that Ag-specific priming of CD8 T cells during a sys-
temic bacterial infection is transient and lasts only 72 h de-
spite the persistence of viable bacteria (3). These authors
hypothesized that there was a feedback mechanism that reg-
ulated the magnitude of CD8 T cell responses. This is com-
patible with the theory that naive T cells can be pro-
grammed with very short exposure to Ag/APCs, and further
division and differentiation of T cells would be independent
of additional Ag stimulation and would instead be driven by
inflammatory mediators (8). However, several groups have
shown that although a single brief exposure to Ag stimula-
tion was sufficient to induce extensive proliferation of naive
T cells, the acquisition of effector functions in vitro de-
pended on more stringent Ag presentation requirements (9,
10, 40–42). In particular, Storni et al. reported that a single
injection of lymphocytic choriomeningitis virus–derived Ag
peptide was sufficient to stimulate Ag-specific CD8 T cells
to undergo multiple rounds of proliferation in vivo, but that
vaccination with peptide alone failed to generate IFN-
 
 
 
–
producing effectors. Only when peptide Ag was presented
by activated APCs or was maintained in the host for several
days did the Ag-specific T cells differentiate to produce
IFN-
 
 
 
 (43). A recent report by Harari et al. went on to sug-
gest that infectious pathogens that are cleared rapidly are as-
sociated with a lesser degree of CD4 T cell differentiation,
that pathogen persistence resulting in low Ag levels generates
an intermediate level of T cell differentiation, and that
highly Th1 cell–polarized T cell differentiation requires pro-
Figure 7. Late phases of influenza-derived Ag presentation signifi-
cantly contribute to the generation of memory T cells. Sham or 
thymectomized BALB/c mice were infected with PR8 virus, and endogenous 
influenza-specific CD4 T cell responses were assayed by ELISPOT at (A) 7 
and (B) 26 d after infection. Values represent the mean   SD. 
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longed pathogen persistence and high Ag levels (23). How-
ever, this report was limited by its inability to control for the
duration and dose of Ag exposure and only used telomere
length and Ag-specific stimulation for 16 h as an indication
of prior Ag exposure. We were able to precisely define the
time at which the T cells first encountered Ag in order to
determine the impact that different stages of influenza-
derived Ag presentation had on CD4 T cell expansion, dif-
ferentiation, and persistence.
Our analyses suggest that although later phases of influ-
enza-derived Ag presentation, and presumably limited expo-
sure to Ag, are capable of driving multiple rounds of CD4 T
cell division, prolonged exposure to Ag or Ag presented on
highly activated APCs may be required for the generation of
highly differentiated effector and memory CD4 T cells capa-
ble of producing high levels of IFN-
 
 
 
 at the site of infection.
We suspect that the level of influenza-derived Ag presenta-
tion follow the rapid kinetics of viral expansion and contrac-
tion, except perhaps with a short lag to accommodate the
time required for Ag uptake and processing by APCs. The
early phase of influenza-derived Ag presentation most likely
provided high levels of inflammation-induced costimulatory
signals, access to live virus with the likelihood of higher Ag
load, potentially few (if any) regulatory cells (44), and
enough time for primary CD4 T cells to progress through
many thresholds of proliferation and differentiation. As a re-
sult, a large proportion of highly differentiated effectors were
likely to be terminally differentiated as they were continually
exposed to long-lived Ag presentation and were thus not se-
lected to enter the memory pool, possibly because of an in-
ability to access and/or use survival signals. We would sug-
gest that the slow acquisition of a medium to a highly
differentiated phenotype, like that which can be accom-
plished when new naive CD4 T cells enter the response
when high levels of inflammation and/or Ag presentation
are subsiding, may allow a smaller number of CD4 effectors
to better survive to memory. In fact, an earlier report by Wu
et al. demonstrated that highly differentiated Th1 effectors,
resulting from multiple in vitro stimulations, were short
lived and did not persist efficiently into long-term memory,
whereas activated effectors that had not yet progressed to an
IFN-
 
 
 
–secreting phenotype persisted into long-term mem-
ory (45). Our own results added support to this theory and
suggested that new naive CD4 T cells exiting the thymus af-
ter viral clearance engage low levels of persisting influenza-
derived Ag presentation and contribute to 
 
 
 
50% of the en-
dogenous memory population (Fig. 7). Additionally, we
found that effectors capable of migrating efficiently to the
lung early in the CD4 T cell response to influenza decayed
rapidly over time, suggesting that the lung environment
could have added to the elimination of highly differentiated
effectors. Later phases of influenza-derived Ag presentation
occurred when inflammation was diminishing, with no de-
tectable access to live virus, and one might thus assume
lower Ag load. It was also possible that regulatory cells were
emerging to control the extent of the immune response after
the pathogen had been eliminated (44).
We have previously reported that long-lived memory
CD4 T cells are maintained in the absence of Ag or persis-
tent pathogen. In fact, the adoptive transfer of effectors into
MHC class II–deficient hosts indicated that CD4 memory T
cells could be generated and maintained in the absence of
additional Ag/MHC class II stimulation (46). One possible
mechanism of the enhanced persistence of intermediately
differentiated T cells could be that effectors generated by
transfer of naive CD4 T cells after virus clearance or the
emergence of new naive CD4 T cells from the thymus may
be less likely to reencounter Ag as it is slowly disappearing
and thus be less susceptible to programmed or activation-
induced cell death (47).
The generation of intermediately differentiated effectors
during late phases of influenza-derived Ag presentation,
when Ag load is presumably very low, is consistent with the
findings of Zaph et al. that, although 
 
Leishmania major
 
–spe-
cific memory CD4 T cells can develop in the absence of
pathogen, the memory T cells maintained in the absence of
pathogen migrate to the LNs and do not produce IFN-
 
 
 
(48). Our findings indicate that later phases of pathogen-
derived Ag presentation are much less efficient at driving ro-
bust expansion and differentiation of primary effectors, yet
result in persisting CD4 memory T cell populations. The re-
sults presented here provide the first direct in vivo evidence
for the hypothesis put forth by Wang and Mosmann, as well
as Lanzavecchia and Sallusto, that resting memory CD4 T
cells may be generated from CD4 effectors at an intermedi-
ate stage of differentiation and that these partially primed T
cells may constitute a pool of persisting Ag-specific T cells
that provide extra flexibility for immune responses on subse-
quent pathogen challenge (49–52).
Collectively, these results suggest that extremely strong pri-
mary stimulation may not necessarily produce the best long-
term CD4 T cell–mediated protection. Specifically, vaccines
directed toward generating the most CD4 T cell memory
should be designed to generate intermediate instead of highly
differentiated effectors. We do not know the origin of the Ag
presentation occurring during any of the phases of influenza in-
fection, but it is possible that an undetected reservoir of virus
exists, perhaps within the APC population. It is also possible
that virus is completely cleared and a reservoir of Ag persists in
protein or peptide form. The broad polyclonal CD4 T cell
response was induced by both early and late phases of influ-
enza-derived Ag presentation and seems most consistent with
prolonged retention of whole virus or viral proteins. Because
preliminary evaluation of APC populations in the lungs, DLNs,
and spleens of influenza-infected mice during the early and late
phases of influenza infection have not revealed any obvious al-
terations in APC populations (unpublished data), defining the
APCs responsible for inducing late-phase Ag stimulation may
provide critical insights necessary to develop the protocols that
will optimally induce a persisting CD4 memory population. 
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Another question raised by these studies is how this per-
sisting Ag presentation would affect an endogenous CD4 T
cell response. We have shown evidence to suggest that as the
immune system produces new naive T cells from the thy-
mus, albeit at a reduced rate into adulthood (53), the new
naive CD4 T cells arriving into the periphery after viral
clearance become primed by long-lived influenza-derived
Ag presentation in the weeks to months after infection. This
late phase of naive CD4 T cell recruitment contributed con-
siderably to the optimal generation of a persisting population
of memory CD4 T cells. Our transfer model systems sug-
gested that late phases of influenza-derived Ag presentation
produced effectors of intermediate levels of differentiation.
We would suggest that naive CD4 T cells that emerge from
the thymus after viral clearance and encounter long-lived in-
fluenza-derived Ag presentation may provide a source of ef-
fectors that are not completely differentiated and may con-
tribute to the generation of a memory subset whose function
is to rapidly produce IL-2 and promote faster recall responses
on reinfection. Alternatively, previous studies (7, 54), as well
as our findings in this study, provide evidence that highly dif-
ferentiated CD4 effector T cells, capable of making high levels
of IFN-
 
 
 
 and very little IL-2 at the effector stage, regain the
capacity to produce IL-2 as they progress to a resting memory
state. The late recruitment of naive CD4 T cells to the re-
sponse by prolonged but low levels of pathogen-derived Ag
presentation may contribute to memory heterogeneity. After
reinfection, either the intermediately differentiated memory T
cells differentiate further, on strong Ag stimulation by acti-
vated APCs, to give rise to completely functional antiviral ef-
fectors, or the highly differentiated effectors that survive to
memory rapidly reexpress high levels of IFN-
 
 
 
 in order to
provide more immediate protection. Whatever mechanisms
are involved in regulating the phases of pathogen-derived Ag
presentation to CD4 T cells, understanding the late phases of
Ag presentation during acute infections may be important in
generating optimum CD4 T cell memory.
 
MATERIALS AND METHODS
 
Mice.
 
HNT TCR Tg mice were backcrossed for 
 
 
 
12 generations to
BALB/c ByJ and crossed to Thy1.1xBALB/c mice to generate
HNTxThy1.1 F1 mice. All TCR Tg mice were used at 4–6 wk of age.
HNTxThy1.1 F1, BALB/c, and Thy1.1xBALB/c mice were bred at the
Trudeau Institute’s animal breeding facilities. Thymi were removed from
BALB/c ByJ mice under nembutal anesthesia (Abbott) and allowed to re-
cover for 10 d before use. All experimental procedures involving mice were
approved by the Trudeau Institute’s animal care and use committee.
 
Naive CD4 T cell isolations and CFSE labeling.
 
Pooled spleen and
LN cells were enriched for naive CD4 T cells by antibody and complement
depletion and Percoll gradient separation as previously described (10). The
purified cell populations were routinely 
 
 
 
85% CD4
 
 
 
 cells, 90–95% of
which had a naive phenotype (CD45RB
 
hi
 
, CD62L
 
hi
 
, CD44
 
low
 
, or CD25
 
low
 
)
and were TCR Tg. Purified naive CD4 T cells were stained, as indicated in
the figure legends, with CFSE (Molecular Probes Inc.) by resuspending
CD4 T cells in serum-free RPMI 1640 (GIBCO BRL) at 10 
 
 
 
 10
 
6
 
 cells/
ml, adding 1 
 
 
 
M CFSE, incubating at 37
 
 
 
C for 15 min, and washing cells
before use.
 
Virus infections and T cell transfers.
 
The A/PR/8/34 (PR8) strain of
influenza A virus was produced in the allantoic fluid of 10-d-old embryo-
nated chicken eggs and characterized by a core facility at the Trudeau Insti-
tute from an aliquot originally obtained from D. Morgan (The Scripps Re-
search Institute, La Jolla, CA). Mice were inoculated intranasally during
light isoflurane anesthesia (Webster Veterinary Supply, Inc.) with 0.1 LD
 
50
 
(5 
 
 
 
 10
 
3
 
 PFU/ml) of virus in 100 
 
 
 
l PBS. X31 influenza A virus was pro-
vided by D. Woodland (Trudeau Institute, Saranac Lake, NY), and mice
were inoculated intranasally with 0.1 LD
 
50
 
 (300 EIU
 
50
 
) of X31 virus in 100
 
 
 
l PBS, as indicated in the figures. 2 
 
 
 
 10
 
6
 
 naive Thy1.1 HNT TCR Tg
CD4 T cells (6) or 10 
 
 
 
 10
 
6
 
 naive Thy1.2 BALB/c polyclonal CD4 T cells
were transferred in 200 
 
 
 
l PBS by i.v. injection into BALB/c or
Thy1.1xBALB/c mice, respectively.
 
Viral plaque assay.
 
Viral titers in lungs and DLNs (parathymic and medi-
astinal LNs) were determined using a modified 5 
 
 
 
 10
 
3
 
 PFU/ml Madin
Darby canine kidney (MDCK) cell plaque assay (55). At various times after
infection, lungs and DLNs were harvested into 1 ml DMEM media
(GIBCO BRL), homogenated, serially diluted, and added to duplicate con-
fluent monolayers of MDCK cells for 1 h at 37
 
 
 
C. Each well was then cov-
ered with 1 ml of agar overlay (DMEM plus 0.2% BSA, 2 mg/ml
NaHCO
 
3
 
, 2 mM Hepes, PSG, 0.5% agar, 0.01% DEAE dextran, and 0.5
 
 
 
g/ml trypsin; Sigma-Aldrich). After 2–3 d of incubation at 37
 
 
 
C, cells
were fixed with 0.5 ml of carnoy’s fixative and stained with 2% crystal vio-
let in 20% ethanol (Sigma-Aldrich). PFU/ml 
 
 
 
 (mean number of plaques/
0.1) 
 
 
 
 (1/dilution factor).
 
Tissue preparation.
 
Donor Thy1.1 HNT TCR Tg CD4 T cells or
Thy1.2 polyclonal CD4 T cells were isolated from DLNs, spleens, and
lungs of experimental mice at the effector (day 7) or memory (days 21–28)
stages after transfer. Mice were exsanguinated under lethal i.p. avertin anes-
thesia by perforation of the abdominal aorta. Lungs were perfused with 10–
20 ml PBS to remove blood lymphocytes. Cell suspensions were prepared
by mechanical disruption of organs and passage through a nylon membrane.
RBCs were lysed using RBS lysis buffer (BD Biosciences) according to the
manufacturer’s protocol.
 
Flow cytometry.
 
Cell suspensions were incubated on ice with saturating
concentrations of fluorochrome-labeled mAbs in FACS buffer (PBS plus
0.5% BSA and 0.02% NaN
 
3
 
; Sigma-Aldrich). Allophycocyanin-labeled
anti-CD4 and PerCP-labeled anti-Thy1.1 or anti-Thy1.2 (BD Biosciences)
were used to identify donor T cells. FITC-labeled anti–L-selectin (CD62L),
and isotype controls were used for phenotype analysis (BD Biosciences).
FACS analysis was performed using FACSCalibur (BD Biosciences) and
FlowJo (Tree Star, Inc.) software.
 
Intracellular cytokine staining.
 
Donor T cells harvested from experi-
mental mice were restimulated for 4 h with 10 ng/ml PMA and 50 ng/ml
ionomycin (Sigma-Aldrich) or for 6 h with 106 HNT-pulsed A20 B cell
lymphoma APCs at a concentration of 106 total cells/ml. 10  g/ml Brefel-
din A (Sigma-Aldrich) was added for the final 2 h of culture and maintained
throughout the intracellular cytokine staining. Donor T cells were surface
stained with anti-Thy1.1, or anti-Thy1.2, and anti-CD4 as described above,
fixed in 100  l 4% paraformaldehyde, and stained in saponin buffer (PBS
plus 1% FBS, 0.1% NaN3 and 0.1% saponin; Sigma-Aldrich) containing
anti–IFN- –PE.
ELISPOT assay for IFN- –secreting cells. Multiscreen HA plates
(Millipore) were coated overnight with anti–IFN-  antibody (clone R4-
6A2; BD Biosciences) at 5  g/ml in PBS. Plates were washed with PBS/
Tween 20 and blocked using complete RPMI 1640 media with 10% FBS.
DLN or lung cells were added at 106 cells/well and serially diluted 1:2 in
RPMI media. Irradiated naive splenocytes were added as APCs with or
without MHC class II–restricted PR8 HA126–138 and nucleoprotein216–230
peptides. Plates were incubated overnight at 37 C, washed with PBS/JEM VOL. 202, September 5, 2005 705
ARTICLE
Tween 20, and incubated with biotinylated anti–IFN-  antibody (clone
XMG1.2; BD Biosciences) at 1  g/ml overnight at 4 C. Plates were
washed with PBS/Tween 20 and incubated with streptavidin–alkaline
phosphatase (ExtraAvidin; Sigma-Aldrich) at 1:500 for 1 h at 25 C. Spots
were developed using 5-bromo-4-chloro-3-indolyl phosphate/nitroblue
tetrazolium (BCIP/NBT; Sigma-Aldrich) tablets dissolved in double-dis-
tilled H2O at 1 mg/ml. The reaction was terminated with H2O, the plates
were dried, and spots were counted using a dissecting microscope
(SMZ800; Nikon Instrument Inc.). Data is plotted as the number of IFN- 
spots per 1.2   105 (DLN and lung effectors and lung memory) or 2.5  
105 (DLN memory) input cell number. Two-tailed Student’s t test was used
to determine statistical differences between groups.
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